The first Paratek Pharmaceuticals trade was made in Q2 2015.
Since then Ken Griffin bought shares 32 more times and sold shares on 34 occasions. The investor completely sold their stake between Q1 2023 and Q3 2023.
Avg closing price
Price range
Sold -203 Thousand shares
Q1 2023
Avg closing price
$1.98
Price range
$1.37
-
$2.54
Increased shares by 385.1% (+161 Thousand shares)
Q4 2022
Avg closing price
$2.49
Price range
$1.67
-
$3.56
Sold 58.1% shares (-58 Thousand shares)
Q3 2022
Avg closing price
$2.49
Price range
$1.96
-
$2.93
Sold 10.1% shares (-11.2 Thousand shares)
Q2 2022
Avg closing price
$2.18
Price range
$1.73
-
$3.09
Sold 34.6% shares (-58.6 Thousand shares)
Q1 2022
Avg closing price
$3.76
Price range
$2.94
-
$4.77
Increased shares by 518.3% (+142 Thousand shares)
Q4 2021
Avg closing price
$4.74
Price range
$4.07
-
$5.30
Sold 0.1% shares (-16 shares)
Q3 2021
Avg closing price
$5.51
Price range
$4.70
-
$7.24
New holding (+27.5 Thousand shares)
Q2 2021
Avg closing price
$8.08
Price range
$6.81
-
$10.93
Sold -35.7 Thousand shares
Q3 2020
Avg closing price
$4.95
Price range
$4.19
-
$6.69
Increased shares by 23.9% (+6.88 Thousand shares)
Q2 2020
Avg closing price
$4.44
Price range
$2.97
-
$5.22
Sold 65.6% shares (-55 Thousand shares)
Q1 2020
Avg closing price
$3.69
Price range
$2.67
-
$4.97
Increased shares by 0.7% (+560 shares)
Q4 2019
Avg closing price
$3.47
Price range
$2.93
-
$4.50
Sold 27.2% shares (-31 Thousand shares)
Q3 2019
Avg closing price
$4.00
Price range
$3.08
-
$5.76
Increased shares by 7.2% (+7.64 Thousand shares)
Q2 2019
Avg closing price
$4.76
Price range
$3.47
-
$6.32
Sold 5.0% shares (-5.65 Thousand shares)
Q1 2019
Avg closing price
$6.46
Price range
$5.36
-
$7.24
Increased shares by 111.4% (+59.2 Thousand shares)
Q4 2018
Avg closing price
$7.59
Price range
$4.80
-
$11.60
Sold 81.0% shares (-227 Thousand shares)
Q3 2018
Avg closing price
$10.09
Price range
$9.05
-
$10.95
Increased shares by 85.7% (+129 Thousand shares)
Q2 2018
Avg closing price
$11.32
Price range
$10.20
-
$13.90
Increased shares by 368.9% (+119 Thousand shares)
Q1 2018